FDA Approved: RIVASTIGMINE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for rivastigmine filed by Sandoz Inc, resulting in an approved modification to the existing rivastigmine approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Parkinson Disease Dementia

Drugs mentioned

• Rivastigmine (Rivastigmine)

Snippet

SUPPL AP for RIVASTIGMINE (RIVASTIGMINE)